INDIANAPOLIS, Oct. 29 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer ...

INDIANAPOLIS, Sept. 13 /PRNewswire-FirstCall/ -- Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food ...

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum ...

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas® 6000 analyzer series, an ...

Cobas pure integrated solutions is a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources. Roche announced ...

Platelet function testing technology will complement Roche's full line of coagulation analyzers targeted for introduction in US and Canada in 2014 The acquisition supports plans Roche announced in ...

BETHLEHEM, Pa., March 3, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) and Roche announced today that the U.S. Food and Drug Administration ("FDA") has granted the Companies 510(k) ...

An essential component in the development and control of bioprocesses for industrial production of recombinant proteins is the delivery of fast, accurate, and reliable process data. The precise ...

Mumbai: Roche Diagnostics launched the cobas pure integrated solutions analyzer with an advanced system which can significantly improve the testing efficiency of labs and hospitals operating in India.

DUBLIN--(BUSINESS WIRE)--The "Clinical Chemistry Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ...